126 results
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
28 Mar 24
Current report (foreign)
1:21pm
highlights both companies' commitment to innovation, excellence, and the development of solutions that not only meet the current needs of the healthcare … and Head of Innovation of BioStrand. "We are at the cusp of a new era in AI-driven applications, where the integration of sophisticated data analysis
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
20 Mar 24
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
12:02pm
and leveraging technology to drive innovation and efficiency, particularly in AI-driven drug design. Carterra's LSA instrument delivers significant
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
14 Mar 24
Current report (foreign)
8:00am
innovation.
AI for Drug Discovery
The initial stage of the drug discovery process involves identifying a therapeutic target followed by the discovery
6-K
EX-99.2
IPA
ImmunoPrecise Antibodies Ltd
14 Mar 24
Current report (foreign)
8:00am
VLAIO (Flanders Innovation & Entrepreneurship), the research fund of the Flemish regional government in Belgium. During the nine months ended January 31
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
7 Mar 24
Current report (foreign)
11:19am
Dirk Van Hyfte MD, PhD, Co-Founder and Head of Innovation of BioStrand, to
present findings live next week at the HIMSS24 conference in Orlando … the facilitation of targeted treatments and the innovation of novel therapies, the HYFT technology offers a reduction in development timelines and costs
6-K
tbgv9 hcqyizcb
7 Mar 24
Current report (foreign)
11:19am
424B5
dcihg7p
23 Feb 24
Prospectus supplement for primary offering
5:26pm
6-K/A
EX-99.2
gkkq3anz8xmea30f7m
15 Feb 24
Current report (foreign) (amended)
3:12pm
6-K
EX-99.1
j3rafbmklub0d xfba
14 Dec 23
Current report (foreign)
8:38am
6-K
EX-99.2
vdab9u1uyy4 woqcm2bz
14 Dec 23
Current report (foreign)
8:38am
424B5
v6gv8gj
7 Dec 23
Prospectus supplement for primary offering
4:53pm
424B5
w3l4hhjyz4nm4
5 Dec 23
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
r8y56 iwlba36e
27 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:31am
6-K
EX-99.1
t6aytl2 hy8en1p
13 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:50am
6-K
EX-99.1
n5ab9wgvaoowssg
25 Oct 23
BioStrand Unveils Groundbreaking Retrieval Augmented Generation (RAG)-Based LLM Platform Integrated with Patented HYFT Technology
8:01am
6-K
EX-99.1
i4baen
23 Oct 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
EX-99.1
2nrv2coz6 rgc8r824u
20 Oct 23
Current report (foreign)
2:56pm
6-K
EX-99.2
epg831v8hrtrsins
14 Sep 23
Current report (foreign)
8:02am
6-K
EX-99.1
7sj98rr
14 Sep 23
Current report (foreign)
8:02am
6-K
EX-99.1
84fe 301qxftz
14 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:01am